271 related articles for article (PubMed ID: 29309783)
1. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
4. Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection.
Sánchez VR; Fenoy IM; Picchio MS; Soto AS; Arcon N; Goldman A; Martin V
Acta Trop; 2015 Oct; 150():159-65. PubMed ID: 26200784
[TBL] [Abstract][Full Text] [Related]
5. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.
Martin V; Supanitsky A; Echeverria PC; Litwin S; Tanos T; De Roodt AR; Guarnera EA; Angel SO
Clin Diagn Lab Immunol; 2004 Jul; 11(4):704-10. PubMed ID: 15242945
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
[TBL] [Abstract][Full Text] [Related]
8. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
[TBL] [Abstract][Full Text] [Related]
9. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
10. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
11. A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice.
Del L Yácono M; Farran I; Becher ML; Sander V; Sánchez VR; Martín V; Veramendi J; Clemente M
Plant Biotechnol J; 2012 Dec; 10(9):1136-44. PubMed ID: 23020088
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice.
Zhang J; He S; Jiang H; Yang T; Cong H; Zhou H; Zhang J; Gu Q; Li Y; Zhao Q
Parasitol Res; 2007 Jul; 101(2):331-8. PubMed ID: 17265053
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
[TBL] [Abstract][Full Text] [Related]
14. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
[TBL] [Abstract][Full Text] [Related]
15. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
Jongert E; de Craeye S; Dewit J; Huygen K
Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.
Li WS; Chen QX; Ye JX; Xie ZX; Chen J; Zhang LF
Parasitol Res; 2011 Sep; 109(3):637-44. PubMed ID: 21404064
[TBL] [Abstract][Full Text] [Related]
19. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
